Although the recurrence rate is lower and tumor progression-free survival is increased in glioblastoma patients with MGMT methylation compared with non-methylated glioblastoma, not all patients with MGMT methylation-positive glioblastoma respond to alkylating agents, and even those who respond eventually show relapse [5]. Here, MGMT is linked to neoplasm.